Asylia Diagnostics Company
Asylia Diagnostics - precision medicine data platform for immunotherapies
Funding Status:
Seed
Headquarters:
Delaware City, Delaware, United States
Founded Date:
2019-08-22
Employee Number:
45200
Last Funding Type:
Series B
Total Funding:
1100000.0
Estimated Revenue:
Less than $1M
Industry:
Medical BioTech
Investors Number:
2.0
Technology:
['BioTech & HealthTech']
Investor Type:
andrey.khmelevskiy@asyliadx.com
Last Funding Date:
2020-03-02